SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer

Some cancers evade targeted therapies through a mechanism known as lineage plasticity, whereby tumor cells acquire phenotypic characteristics of a cell lineage whose survival no longer depends on the drug target. We use in vitro and in vivo human prostate cancer models to show that these tumors can...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Science
Main Authors: Mu, Ping, Zhang, Zeda, Benelli, Matteo, Karthaus, Wouter R., Hoover, Elizabeth, Chen, Chi-Chao, Wongvipat, John, Ku, Sheng-Yu, Gao, Dong, Cao, Zhen, Shah, Neel, Adams, Elizabeth J., Abida, Wassim, Watson, Philip A., Prandi, Davide, Huang, Chun-Hao, de Stanchina, Elisa, Lowe, Scott W., Ellis, Leigh, Beltran, Himisha, Rubin, Mark A., Goodrich, David W., Demichelis, Francesca, Sawyers, Charles L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5247742/
https://ncbi.nlm.nih.gov/pubmed/28059768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aah4307
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados